Milestone Pharmaceuticals announces FDA acceptance of response to Cardamyst nasal spray CRL
Milestone also announced the extension of its $75 million Royalty Purchase Agreement with RTW Investments
Milestone also announced the extension of its $75 million Royalty Purchase Agreement with RTW Investments
Finerenone significantly reduced the combined risk of cardiovascular death and total (first and recurrent) heart failure events,
Capricor’s BLA for Deramiocel received Priority Review in March 2025
GII is a leading investment firm with assets under management exceeding US$ 3.5 billion with presence across Saudi Arabia, UAE, Europe, USA and India
Ukhade brings deep expertise in large-scale infrastructure planning, cross-functional leadership, and project innovation.
LEQSELVI now available for prescription in U.S. nationwide, offering a new option for eligible patients
Apotex will also pay US$ 2.5 million upon receipt of final USFDA approval of the ANDA that is the subject of the Collaboration Agreement for Paclitaxel Protein-Bound Particles for Injectable Suspension
The company’s largest center for medical device applications, serving the entire Asian market
This collaboration marks a significant milestone for Abluva as the company aims to deliver value and innovative solutions in agentic AI security
To streamline complex medical writing workflows with GenAI
Subscribe To Our Newsletter & Stay Updated